Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-04-27
1989-09-12
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514180, A61K 3156
Patent
active
048660507
ABSTRACT:
A dexamethasone delivery composition includes dexamethasone disposed in a cellulosic gel, preferably a hydroxycellulose gel. Lidocaine solubilizes the dexamethasone into the gel to provide a dexamethasone composition of increased concentration and enhanced tissue penetration capability. A method for the transdermal delivery of dexamethasone includes the step of applying the dexamethasone gel composition of the invention to the tissue of a patient and applying ultrasound at the site to effect penetration of the dexamethasone.
REFERENCES:
patent: 3007923 (1961-11-01), Muller et al.
patent: 3962430 (1976-06-01), O'Neill
patent: 4440777 (1984-04-01), Zupan
patent: 4482539 (1984-11-01), Sandweiss et al.
patent: 4701451 (1987-10-01), Annen et al.
patent: 4710497 (1981-12-01), Heller et al.
Lipovsky Joseph A.
Robinson Douglas W.
LandOfFree
Ultrasonic transdermal application of steroid compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ultrasonic transdermal application of steroid compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ultrasonic transdermal application of steroid compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-916369